Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers - Wikidata - wikimedia - TriplyDB

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

http://www.wikidata.org/entity/Q27490989

about

The dengue vaccine pipeline: Implications for the future of dengue control Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus Trends in clinical trials of dengue vaccine Dengue: a continuing global threat Issues related to recent dengue vaccine development.Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses.Dengue vaccines: recent developments, ongoing challenges and current candidates.Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.Serologic imprint of dengue virus in urban Haiti: characterization of humoral immunity to dengue in infants and young children Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.Natural products as source of potential dengue antivirals.Recent progress in dengue vaccine development.Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.The necessity and quandaries of dengue vaccine development.

P2860

Q26314683-6FD8EC03-F8C4-4621-80A8-502F3B141C69 Q27680467-DF2CE400-BAD8-4F05-8A20-40571BCEA8E3 Q28074355-C10DDAE1-008F-428C-B78C-C97175535517 Q28298464-7488BD41-166B-4117-A57F-171CE408F9FF Q30395396-C2AFE052-6B9B-475D-A6F5-3C555C8CEC82 Q30400192-765C412C-7764-4CE2-8555-F2727D478BA7 Q34367194-341B273D-F0B9-4D25-BA2D-E322134CEDCF Q34630584-48F965F5-B6CB-46FE-A0B1-2C1DBBA4D26B Q34707858-04477A9F-3526-446B-ABEF-A553E39A8341 Q35206695-B6738FBC-38DF-43BE-A01E-8AA30ABC05BD Q36181531-52109D0F-EEAA-4FC6-902C-02B2FEEDC587 Q36288109-E166F57F-9F57-491D-B8F6-B300B27AF102 Q37184768-C91E5255-CBC4-4C66-B479-7284F4FCB279 Q37812291-B26104F6-6199-45CE-879D-83254D4600DC Q38221220-A07C3301-AD29-4AEE-8787-55D14D765CD8 Q38303232-2728B611-D4C0-4BA4-A6B9-57AD28870EF3 Q39118535-596A9D89-5369-4E1C-904D-4245C3E5617E Q42710655-DEFE794C-8437-4A3C-B51D-8BD5FF190DC7

P2860

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

http://www.wikidata.org/entity/Q27490989

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@ast

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@en

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@nl

type

label

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@ast

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@en

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@nl

prefLabel

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@ast

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@en

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@nl

P1433

Q27490989-C67B4C44-819A-4412-A238-D173373D02E0

P1476

Q27490989-4A55EBD7-0195-4E18-96A4-D1D276C64170

P2093

Q27490989-0C181460-B13F-4916-86AD-76797FEF56F8

Q27490989-1338AF70-677A-4163-8619-A74767C28756

Q27490989-2EDD6883-1A54-4569-B4BD-7F7AAF615977

Q27490989-553D67FD-5A9F-4C9C-BFB9-CB6AA193B66B

Q27490989-80B8034D-0F18-407C-A64C-5E666F974B44

Q27490989-8AD2B61A-66DF-457A-B4BB-06A548574618

Q27490989-C790404A-4A0B-4FA2-845B-7A7E782252A8

Q27490989-C8A2B3B6-09D3-49C0-9472-0869B47A6849

Q27490989-C9E81FF5-D9EC-44A1-8119-F1BA92CEA279

Q27490989-EC9D2106-707D-4CAD-A169-BCC7B2951228

P2860

Q27490989-079420D2-33AA-4581-8382-FC05F95F6D06

Q27490989-0D287D1E-9A5C-4A2A-89D6-1653B59156DA

Q27490989-0DD38D3D-A3BF-403B-B17C-E9D203683257

Q27490989-10CEE95F-7957-4E86-8EF8-64998DD74CC8

Q27490989-223E4C35-9800-4A14-8D03-3EBDBC4AAD60

Q27490989-24250422-8C89-498C-A7E4-A3170C65CCBD

Q27490989-25B90EFF-8DBA-4237-8223-0A5902D62D52

Q27490989-38C34C1B-5BC1-4AC7-90E8-504BD2D2427F

Q27490989-3D7A9998-9B53-4F06-9A13-DFE5434DAA10

Q27490989-44482366-E1DF-4C12-8F28-E7B3F006687E

P304

Q27490989-7C0ECAFE-E8E3-4DBD-9696-30785EEB4B8A

P31

Q27490989-4BB21E9D-520F-4C66-967B-3A822BD772E4

P3181

Q27490989-EC82BF04-65FC-4DFD-89D7-DE6000DBC1E0

P356

Q27490989-2A1D2743-1E61-470A-8912-FC2168200005

P407

Q27490989-63970CD0-904E-40A9-9BE1-B618D6D831D2

P433

Q27490989-8BC1F47B-3A93-44A8-890F-1E1F86ACAF8D

P478

Q27490989-46648B6D-1EBE-4BF3-997A-64B6076881EB

P50

Q27490989-9351236B-505D-4BF6-9FFA-BD07D44564EF

Q27490989-B51A6377-F5BE-4E0C-B6D3-F258D29B0649

P577

Q27490989-89C8E4D1-B185-46EC-BAEF-1C3C4D9183A2

P5875

Q27490989-C209907D-8DC7-4D0E-86EC-ADC5FF486003

P698

Q27490989-70C5D1F4-A060-40F0-9D39-E6A18FBDB462

P921

Q27490989-52531A6C-4902-45F6-9321-D1746AF3962D

Q27490989-DF440BA1-C8EC-444F-A6DE-F34A1A55C1C9

P932

Q27490989-C0B936A5-FABC-42DE-ADD9-5FA0CBE90064

P3181

P356

AJTMH.2009.09-0131

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Phase 1 Trial of the Dengue Vi ...... 95 in Healthy Adult Volunteers

@en

P2093

Alexander C Schmidt

http://www.w3.org/2001/XMLSchema#string

Bhavin Thumar

http://www.w3.org/2001/XMLSchema#string

Brett A McKinney

http://www.w3.org/2001/XMLSchema#string

Brian R Murphy

http://www.w3.org/2001/XMLSchema#string

Joseph E Blaney

http://www.w3.org/2001/XMLSchema#string

Michael T Rock

http://www.w3.org/2001/XMLSchema#string

Mine R Ikizler

http://www.w3.org/2001/XMLSchema#string

Peter F Wright

http://www.w3.org/2001/XMLSchema#string

Sharon Ankrah

http://www.w3.org/2001/XMLSchema#string

Susan Henderson

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring the burden of neglected tropical diseases: the global burden of disease framework

Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4

Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

A prospective study of dengue infections in Bangkok

Research on dengue during World War II

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

P304

834-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3191727

http://www.w3.org/2001/XMLSchema#string

P356

10.4269/AJTMH.2009.09-0131

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Stephen S Whitehead

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38040824

http://www.w3.org/2001/XMLSchema#string

P698

19861619

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

2829759

http://www.w3.org/2001/XMLSchema#string